Ifi204 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
IFI204 (Interferon Alpha Inducible Protein 204), also known as AIM2 (Absence in Melanoma 2) or PYHIN1, is a member of the AIM2-like receptor (ALR) family of proteins. This gene encodes a cytosolic DNA sensor that plays a critical role in innate immunity and inflammasome activation. While traditionally studied in the context of cancer and autoimmune diseases, emerging research reveals important functions in the central nervous system, particularly in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD). [1]
The IFI204 gene spans approximately 21 kb on chromosome 1q23.1 and consists of 8 exons encoding a protein of 414 amino acids with a molecular weight of approximately 46 kDa. The protein structure comprises two key functional domains:
The N-terminal pyrin domain (~90 amino acids) mediates homotypic protein-protein interactions through PYHIN family-specific interactions. This domain allows IFI204 to recruit adapter proteins and initiate downstream signaling cascades.
The C-terminal HIN-200 domain (~200 amino acids) is responsible for DNA binding. This domain contains two OB-fold motifs that together form a single-stranded DNA binding surface. The HIN-200 domain can bind both double-stranded and single-stranded DNA with preference for longer DNA fragments (>80 bp).
IFI204 functions as a canonical cytosolic DNA sensor. Upon binding to foreign or host-derived DNA in the cytosol:
IFI204 can also induce type I interferon (IFN-α/β) production through activation of the STING-TBK1-IRF3 pathway, though this function is more prominent for related family member IFI16.
Key protein interactions include:
In the central nervous system, IFI204 shows a distinctive expression pattern:
| Cell Type | Expression Level | Functional Implications |
|---|---|---|
| Microglia | High | Primary sensor for pathogen DNA |
| Astrocytes | Moderate | Inflammasome in neuroinflammation |
| Neurons | Low-Moderate | Activity-dependent expression |
| Oligodendrocytes | Low | Limited characterization |
| Brain endothelial cells | Low | Blood-brain barrier interface |
IFI204 expression is tightly regulated by:
The AIM2 inflammasome is significantly activated in AD brain tissue:
Elevated IFI204/AIM2 expression has been observed in:
IFI204 is activated in ALS and FTD with TDP-43 pathology:
The C9orf72 repeat expansion, the most common genetic cause of ALS/FTD, may intersect with IFI204 pathways through:
Several approaches are being explored:
Existing drugs with potential:
IFI204/AIM2 represents a critical link between DNA sensing, innate immunity, and neurodegenerative disease pathogenesis. While primarily characterized in peripheral immune cells, emerging evidence demonstrates important functions in brain cells, particularly microglia. The inflammasome activation driven by IFI204 contributes to chronic neuroinflammation in AD, PD, ALS, and FTD. Targeting this pathway offers therapeutic potential, though challenges remain in achieving brain penetration and achieving selective modulation.
Ifi204 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Ifi204 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Choubey D et al. Interferon-inducible IFI16 protein in human cancers (2010). 2010. ↩︎